Cancer
Childhood Solid Neoplasm
CI-CAN-00000138Explore in graph →
PediatricNon-malignant22 active trials
- NCIt
- C9107
Loading cancer entity…
Cancer
CI-CAN-00000138Explore in graph →
Clinical trials
215 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06620302 | Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar Carcinoma | suspended | Phase 1 / Phase 2 | 81 | Children's Oncology GroupNETWORK | 1 | Aug 24, 2026 | clinicaltrials |
| NCT04485416 | Pilot Trial of Eltrombopag in Patients Undergoing Chemotherapy for Malignant Solid Tumors(CCPO011) | suspended | Phase 1 | 10 | University of California, DavisOTHER | 1 | Apr 10, 2025 |
| clinicaltrials |
Data updated 22 days agoSource updated Aug 24, 2026source: clinicaltrials